Published in Placenta on March 03, 2006
Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol (2007) 1.37
Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field. Placenta (2010) 1.09
Antigen-presenting cells represent targets for R5 HIV-1 infection in the first trimester pregnancy uterine mucosa. PLoS One (2009) 1.08
Extravillous trophoblast and decidual natural killer cells: a remodelling partnership. Hum Reprod Update (2012) 1.06
Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin Immunopathol (2007) 1.04
Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance. J Pathol (2012) 1.01
Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface. PLoS One (2010) 0.96
Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro. Am J Pathol (2010) 0.95
Decidual natural killer cell interactions with trophoblasts are impaired in pregnancies at increased risk of preeclampsia. Am J Pathol (2013) 0.95
Human decidual NK cells: unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies. Front Immunol (2013) 0.89
Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads. PLoS One (2010) 0.88
Molecular evidence for natural killer-like cells in equine endometrial cups. Placenta (2012) 0.87
Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol (2014) 0.86
The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy. Cell Mol Immunol (2015) 0.81
Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal Immunity. J Pregnancy (2016) 0.81
Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy. J Clin Endocrinol Metab (2012) 0.81
Hormonal regulation of uterine chemokines and immune cells. Clin Exp Reprod Med (2011) 0.79
Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers. PLoS One (2012) 0.79
Immunology of hepatic diseases during pregnancy. Semin Immunopathol (2016) 0.78
Cell death mechanisms at the maternal-fetal interface: insights into the role of granulysin. Clin Dev Immunol (2011) 0.76
UNK cells: their role in tissue re-modelling and preeclampsia. Semin Immunopathol (2007) 0.75
Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin(-)CD34(+)DNAM-1(bright)CXCR4(+) Cell Progenitor. Front Immunol (2017) 0.75
Upregulated unique long 16 binding protein 1 detected in preeclamptic placenta affects human extravillous trophoblast cell line (HTR-8/SVneo) invasion by modulating the function of uterine natural killer cells. Exp Ther Med (2017) 0.75
MTHFR 3'-untranslated region polymorphisms contribute to recurrent pregnancy loss risk and alterations in peripheral natural killer cell proportions. Clin Exp Reprod Med (2017) 0.75
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA (2001) 2.63
Endoscopic coronary artery bypass grafting with the aid of robotic assisted instruments. J Thorac Cardiovasc Surg (1999) 2.46
Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. J Immunol (1985) 2.37
CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood (1996) 2.30
Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg (1999) 2.24
Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation (2001) 2.20
Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg (2001) 2.16
Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA (1998) 2.01
Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol (1990) 1.99
Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A (1996) 1.80
Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet (1990) 1.75
Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol (2000) 1.67
Homograft replacement of the mitral valve. Graft selection, technique of implantation, and results in forty-three patients. J Thorac Cardiovasc Surg (1996) 1.60
p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci U S A (1991) 1.56
Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. Nature (1988) 1.53
Delineation of an immunoregulatory amplifier population recognizing autologous Ia molecules. Analysis with human T cell clones. J Exp Med (1984) 1.49
Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet (1984) 1.46
Anti-HL-A foeto-maternal immunization. Persistence of antibodies. Tissue Antigens (1973) 1.44
Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol (2001) 1.42
Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol (1992) 1.40
Chronic active hepatitis following splenectomy for autoimmune thrombocytopenia. Isr J Med Sci (1991) 1.40
Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol (2001) 1.38
[Should tocolytics be used in premature rupture of membranes (PROM)? The pros]. Gynecol Obstet Fertil (2008) 1.38
Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS (2000) 1.38
Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation (2001) 1.34
T lymphocytes bearing the gamma delta T cell receptor in patients with acute Plasmodium falciparum malaria. J Infect Dis (1990) 1.32
Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR. J Clin Microbiol (2006) 1.32
Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol (1999) 1.32
Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol (1996) 1.25
IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol (1992) 1.25
Clonotypic surface structure on human T lymphocytes: functional and biochemical analysis of the antigen receptor complex. Immunol Rev (1984) 1.24
Functional isotypes are not encoded by the constant region genes of the beta subunit of the T cell receptor for antigen/major histocompatibility complex. J Exp Med (1984) 1.24
Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz (2009) 1.23
T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane. J Exp Med (1998) 1.22
Regulation of transcription of the human T cell antigen receptor delta chain gene. A T lineage-specific enhancer element is located in the J delta 3-C delta intron. J Exp Med (1990) 1.22
The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur Cytokine Netw (1997) 1.20
ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene (2012) 1.19
Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta (2000) 1.19
A human T lymphoblastic cell line lacks lamins A and C. EMBO J (1987) 1.18
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol (1997) 1.16
Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum. Clin Exp Immunol (1994) 1.14
Double mitral homograft for recurrent bacterial endocarditis of the mitral and tricuspid valves. J Heart Valve Dis (1994) 1.13
Computer-assisted cardiac surgery. Lancet (1999) 1.13
A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med (1993) 1.11
Induction of NF-KB during monocyte differentiation by HIV type 1 infection. J Immunol (1991) 1.10
T3-Ti receptor triggering of T8+ suppressor T cells leads to unresponsiveness to interleukin-2. Nature (1984) 1.09
Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol (1998) 1.09
Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol (2009) 1.08
Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet (1999) 1.07
bcr-abl RNA in patients with chronic myelogenous leukemia. Blood (1987) 1.07
Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol (2011) 1.07
Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation. J Clin Invest (1988) 1.06
Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation (1998) 1.05
HLA-G remains a mystery. Trends Immunol (2001) 1.04
CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol (1996) 1.04
Prolymphocytic transformation of B-chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion. Am J Hematol (1998) 1.04
Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res (1999) 1.04
Interferon: a cytotoxic T lymphocyte differentiation signal. Eur J Immunol (1986) 1.04
Expression of human class I histocompatibility antigens at the surface of DNA-transformed mouse L cells. Immunogenetics (1982) 1.03
Angioplasty balloon occlusion of internal thoracic artery in redo surgery in patients with coronary artery bypass operations. J Thorac Cardiovasc Surg (2001) 1.03
Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biol (2001) 1.03
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J Immunol (1985) 1.02
Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood (1998) 1.02
Less invasive techniques for mitral valve surgery. J Thorac Cardiovasc Surg (1998) 1.02
Reconstructive surgery in congenital mitral valve insufficiency (Carpentier's techniques): long-term results. J Thorac Cardiovasc Surg (1998) 1.02
c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes. Oncogene (2009) 1.01
Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France. J Pediatr (1997) 1.01
Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb. Int Immunol (1995) 1.00
Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol (1997) 1.00
Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur J Immunol (2000) 0.99
Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood (1998) 0.98
Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol (1999) 0.98
CD100 is a leukocyte semaphorin. Cell Mol Life Sci (1998) 0.97
Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity. J Immunol (1987) 0.97
IL-10 producing regulatory B cells in mice and humans: state of the art. Curr Mol Med (2012) 0.96
The human semaphorin-like leukocyte cell surface molecule CD100 associates with a serine kinase activity. J Biol Chem (1997) 0.95
What is a T-cell clone? Effect of rIFN on T-cell clone function and T-cell receptor gene rearrangement. Hum Immunol (1986) 0.95
Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas. Oncogene (2006) 0.95
Lymphocytes subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood. Tissue Antigens (1996) 0.94
Grb7 expression and cellular migration in chronic lymphocytic leukemia: a comparative study of early and advanced stage disease. Leukemia (2004) 0.94
HLA-G unique promoter region: functional implications. Immunogenetics (2001) 0.94
Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones. Proc Natl Acad Sci U S A (1985) 0.94
Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. J Invest Dermatol (2000) 0.94
CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs. J Clin Invest (1998) 0.93
The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells. Eur J Immunol (1992) 0.93
Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol (1993) 0.93
The HLA-G gene is expressed at a low mRNA level in different human cells and tissues. Hum Immunol (1994) 0.93
Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction (2004) 0.92
The human T-cell receptor. J Clin Immunol (1985) 0.92
Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1. J Virol (1998) 0.92
Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS (2000) 0.92
Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas. Br J Dermatol (2014) 0.92
Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia. Leukemia (2007) 0.91
HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol (1999) 0.91